Usually during the third quarter of each year I analyze my portfolio’s performance, do a little tweaking and cast about for an underlying strategy for the new year. 2016 was especially difficult due to a couple of mergers wreaking havoc on my portfolio structure as well as the uncertainty caused by the election. The easy fix is to add to my anchor, core and satellite holdings at reasonable price points to get them to their target weightings. This is illustrated by my recent purchases of KMB, CLX and SBUX with more to come. The more difficult issue was identifying potential value plays for an ancillary portion of the portfolio.
“cant see the forest for the trees”
Simply that you have focused on the many details and have failed to see the overall view, impression or key point. Urban Dictionary
I find it interesting when multiple unrelated occurrences converge and coalesce into a singular thought. Case in point:
- Investment Hunting did a financial quiz with one of the questions being “I’ve never bought a stock on OTC Markets?” Wallet Squirrel’s response (presumably tongue-in-cheek) was, “No, no idea (what) that is. “Octopus Tentacle Club”?”
- DivHut presented his June 2016 stock considerations with a response by Tawcan being, ” … I continue to like V, SBUX, National Bank (not sure if they’re listed in US market) …”
It dawned on me that there was a lack of understanding regarding the OTC (over the counter) market. Without getting into the nuances (grey, pink, etc.), let me just that a significant benefit to US investors is unprecedented access to foreign markets – notably Canada, but also Australia, Singapore and more. In this post, I’ll focus on Canada.